Gilead Sciences News — every source, one live feed

Track Gilead Sciences news in real time — S&P 500 — antiviral biopharma, GILD. fllwup^ collects the latest Gilead Sciences headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.

Latest Gilead Sciences headlines

  • Gilead (GILD) Stock Could Be 50% Undervalued On New Oncology Trial News — Yahoo Finance
  • Gilead: Growth Supports A Hold Despite A Valuation Premium — Seeking Alpha
  • How Investors Are Reacting To Gilead Sciences (GILD) Strong HIV Trial Data — Simply Wall St
  • Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know — Yahoo Finance
  • Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know — Yahoo Finance
  • Gilead (GILD) Stock Looks Undervalued After A 147% Five Year Run — Yahoo Finance
  • Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note — Yahoo Finance
  • Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts — Yahoo Finance
  • Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend? — Yahoo Finance
  • Gilead Sciences (GILD) Wins EU Trodelvy Approval, Is The Stock Fully Priced? — Yahoo Finance

Follow Gilead Sciences live on fllwup^ · Follow in any RSS reader — or browse all topics.

Also tracking

More S&P 500 — Healthcare: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.